First Weight-Loss Tablet Approved for Use in Australia
The Therapeutic Goods Administration cleared various doses of the Wegovy tablet, made by Danish pharmaceutical company Novo Nordisk, on Nov. 3.
Australians can now access weight-loss medication Wegovy in a daily tablet form, medically approved by the Therapeutic Goods Administration on November 3rd. This marks a significant shift from the previously required weekly injection. The approval covers weight management and reducing the risk of major cardiovascular events in eligible adults.
- Australia has approved the first daily tablet version of the weight-loss drug Wegovy.
- The Therapeutic Goods Administration cleared various doses of the Wegovy tablet on November 3rd.
- Previously, Australians could only receive this GLP-1 drug via a weekly injection.
- The daily tablet form was already approved in the UK and the US.
- The medication is approved for weight management and reducing the risk of cardiovascular events like stroke or heart attack in eligible adults.
Write a comment